Lianhuan Pharmaceutical Receives Drug Registration Certificate for Lactulose Oral Solution

Regulation
โดย Jiemian·CN·Read original
Summary · why it matters

Lianhuan Pharmaceutical announced that the company recently received the drug registration certificate for Lactulose Oral Solution approved and issued by the National Medical Products Administration. The drug specifications are 200 ml:133.4 g and 15 ml:10 g, registered as a Category 4 chemical drug, and deemed to have passed the consistency evaluation. The announcement shows that the drug is indicated for the treatment and prevention of chronic or habitual constipation and hepatic encephalopathy.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews